Global Cardiovascular Imaging Equipment Pipeline Report 2022 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cardiovascular Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive information about the Cardiovascular Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiovascular Imaging Equipment are the imaging devices that capture the images of heart to diagnose the condition of heart.

Scope

• Extensive coverage of the Cardiovascular Imaging Equipment under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Cardiovascular Imaging Equipment and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Cardiovascular Imaging Equipment under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Products under Development

3.1 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development

3.2 Cardiovascular Imaging Equipment - Pipeline Products by Territory

3.3 Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path

3.4 Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date

4 Cardiovascular Imaging Equipment - Pipeline Products under Development by Companies

4.1 Cardiovascular Imaging Equipment Companies - Pipeline Products by Stage of Development

4.2 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development

5 Cardiovascular Imaging Equipment Companies and Product Overview

5.1 Aetna Inc Company Overview

5.2 Beth Israel Deaconess Medical Center Company Overview

5.3 CardioPaint Company Overview

5.4 Centerline Biomedical Inc Company Overview

5.5 Cleveland Clinic Hospital Company Overview

5.6 Columbia University Company Overview

5.7 CorVista Health Inc Company Overview

5.8 Echopoint Medical Ltd Company Overview

5.9 Eindhoven University of Technology Company Overview

5.10 ElectroSonix LLC Company Overview

5.11 FMI Medical Systems Inc Company Overview

5.12 Illumasonix LLC (Inactive) Company Overview

5.13 Johns Hopkins University Company Overview

5.14 King's College London Company Overview

5.15 Koninklijke Philips NV Company Overview

5.16 Massachusetts Institute of Technology Company Overview

5.17 Nano4Imaging GmbH Company Overview

5.18 Panoramic Hengsheng (Beijing) Science and Technology Co Ltd Company Overview

5.19 Perinatronics Medical systems Inc Company Overview

5.20 Philips Ultrasound, Inc. Company Overview

5.21 Purdue University Company Overview

5.22 Tribogenics, Inc. Company Overview

5.23 University Health Network Company Overview

5.24 University of Colorado Company Overview

5.25 University of Glasgow Company Overview

5.26 University of Pittsburgh Company Overview

5.27 Vida Medical Devices Inc Company Overview

5.28 Vigilant Medical Inc Company Overview

6 Cardiovascular Imaging Equipment- Recent Developments

6.1 May 10, 2022: Stereotaxis Reports 2022 First Quarter Financial Results

6.2 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022

6.3 Apr 28, 2022: LeMaitre Q1 2022 Financial Results

6.4 Apr 15, 2022: LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022

6.5 Mar 30, 2022: Broncus Medical Announces Annual Results for 2021: Operating revenue for 2021 increased 234.2% year-on-year, while product development and commercialization are steadily advancing.

6.6 Mar 09, 2022: Stereotaxis Announces Grand Opening of New Global Headquarters in St. Louis

6.7 Mar 01, 2022: HeartFlow Announces CEO Transition

6.8 Feb 24, 2022: LeMaitre Q4 2021 Financial Results

6.9 Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022

6.10 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

6.11 Jan 03, 2022: MediBalloon expands operations and establishes mass production capabilities in Taiwan's Medeologix

6.12 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule

6.13 Oct 28, 2021: Stereotaxis to Report Third Quarter 2021 Financial Results on November 11, 2021

6.14 Oct 28, 2021: LeMaitre Q3 2021 Financial Results

6.15 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021

6.16 Oct 19, 2021: Pivotal consensus statement for Medistim's transit time flow technology (TTFM) published in Circulation

6.17 Oct 14, 2021: LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021

6.18 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting

6.19 Aug 13, 2021: Medistim Announces Second quarter and first half financials 2021

6.20 Jul 29, 2021: LeMaitre Q2 2021 Financial Results

6.21 Jul 26, 2021: Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.

6.22 Jul 20, 2021: Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021

6.23 Jul 15, 2021: LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021

6.24 Jul 13, 2021: LeMaitre Provides Q2 2021 Update

6.25 Jun 24, 2021: Peter Arduini named CEO of GE healthcare

6.26 Jun 22, 2021: Angel Medical Systems Announces Brad Snow as Interim Chief Executive Officer

6.27 Jun 03, 2021: GE Healthcare and the American College of Cardiology join forces to advance AI in cardiac care

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/9mxu1c

Source: GlobalData

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900